Today´s healthcare industry depends greatly on complex research and innovation in the pharmaceutical, genetics, biotechnology, and medical devices sectors. A deeper knowledge of pathophysiology and the epidemiologic transition has driven this change, creating as well greater market opportunities. In Mexico, this service represents 5.5% of GDP and generates about 4% of employment in Mexico (INEGI).
Mexico has the second-largest pharmaceutical market in Latin America, and it is also one of the world´s main manufacturing centers with the presence of 20 multinational pharmaceutical companies. In 2013 the sector was valued at 13.98 billion USD. Meanwhile, for that same yea, the exports of medical devices reached 6.89 billion USD. Mexico is the main supplier to the U.S. market.
It is expected that by 2025 the customer engagement within the health sector will be through electronic media in relation to laboratory tests, medications, and medical consultations. Contact Us
